跳至主要内容
临床试验/NCT06189586
NCT06189586Enrolling By Invitation不适用

Comparison of Aerosol Inhalation and Intravenous Glucocorticoid in the Treatment of Severe AECOPD-------Multicenter, Prospective, Randomized, Controlled Clinical Study

Dong Yang1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
100
试验地点
1
主要终点
Relevant indexes after treatment

研究概览

简要总结

Comparison of aerosol inhalation and intravenous glucocorticoid in the treatment of severe AECOPD-------Multicenter, prospective, randomized, controlled clinical study

详细描述

This study aims to compare the efficacy and comprehensive benefits of aerosol inhalation and intravenous injection of glucocorticoids in severe AECOPD patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • (1) Patients with AECOPD requiring hospitalization or emergency treatment (COPD acute attacks combined with respiratory failure were eligible). (2) 18 years of age ≤80 years of age (3) Patients and their families are willing to participate in clinical research and sign informed consent.

排除标准

  • Combined with tuberculosis.
  • Combined bronchiectasis.
  • complicated with definite infectious diseases.
  • PCT≥0.5ng/ml or CRP≥30mg/L.
  • Serious injury combined with other organ functions
  • Contraindications to other glucocorticoid use.
  • Concomitant bronchial asthma or positive bronchodilation test

研究组 & 干预措施

Nebulized inhalation group

Active Comparator

2 mg budesonide suspension for inhalation, nebulized inhalation for minutes,administered 4 times a day for 5 consecutive days.

干预措施: aerosol inhalation of glucocorticoids (Drug)

Intravenous hormone group

Active Comparator

40mg sodium methylprednisolone succinate for injection(dissolved in 0.9% saline or5% glucose injection 50ml), intravenous infusion for 30 minutes, once a day for 5 consecutive days.

干预措施: intravenous injection of glucocorticoids (Drug)

结局指标

主要结局

Relevant indexes after treatment

时间窗: The day of admission, day one, day two, day three, day five, day seven, day ten

Changes in blood gas indexes (oxygenation index, arterial partial pressure of carbon dioxide, pH value) of patients with respiratory rate, blood pressure, heart rate changes

次要结局

未报告次要终点

研究者

发起方
Dong Yang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Dong Yang

Assisted Investigator

Jilin University

研究点 (1)

Loading locations...

相似试验